Tabula Rasa HealthCare Announces Second Quarter 2017 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/23/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
- One killed, three injured when man attacks Swedish school with sword
Tabula Rasa Healthcare (TRHC ) PT Raised to $20 at Piper Jaffray
August 8, 2017 8:25 AM EDTPiper Jaffray raised its price target on Tabula Rasa Healthcare (NASDAQ: TRHC ) to $20.00 (from $19.00) while maintaining a Overweight rating following another strong quarter with upside to revenue and profitability.
Analyst Sean Wieland said they are encouraged by three contracts that remain on track to drive a step-up in... More
Tabula Rasa HealthCare (TRHC) Reports In-Line Q2 EPS
August 7, 2017 4:22 PM EDTTabula Rasa HealthCare (NASDAQ: TRHC) reported Q2 EPS of $0.06, in-line with the analyst estimate of $0.06. Revenue for the quarter came in at $29.7 million versus the consensus estimate of $27.84 million.
For earnings history and earnings-related data on Tabula Rasa HealthCare (TRHC) click here.
... More